Global Radiodermatitis Market Anticipated to Generate a Revenue of $561.7 Million and Rise at a CAGR of 4.1% during the Forecast Timeframe 2021-2028 | Approved [169-Pages] by Research Dive
29 août 2022 09h08 HE
|
Research Dive
New York, USA, Aug. 29, 2022 (GLOBE NEWSWIRE) -- According to a report published by Research Dive, the global radiodermatitis market is envisioned to garner a revenue of $561.7 million and grow at a...
U.S. Compounding Pharmacies Market to hit USD 8.7 Billion by 2030, says Global Market Insights Inc.
07 juil. 2022 06h15 HE
|
Global Market Insights Inc.
Selbyville, Delaware, July 07, 2022 (GLOBE NEWSWIRE) -- U.S. compounding pharmacies market value is set to reach USD 8.7 billion by 2030, according to a new research report by Global Market...
Jerry Grisaffi, CEO of Right on Brands, Discusses New Products, 2021 Milestones and 2022 Goals in Audio Interview with SmallCapVoice.com
08 déc. 2021 08h00 HE
|
Right On Brands, Inc.
AUSTIN, Texas, Dec. 08, 2021 (GLOBE NEWSWIRE) -- SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Right on Brands, Inc. (OTC PINK: RTON), a fully reporting SEC filer...
Global Lyme Disease Treatment Market Projected to Surpass $1,062,794.78 Thousand, Growing at 7.50% CAGR from 2021 to 2028 – Exclusive Report [180 Pages] By Research Dive
15 nov. 2021 09h00 HE
|
Research Dive
New York, USA, Nov. 15, 2021 (GLOBE NEWSWIRE) -- A new report on the global lyme disease treatment market has been added by Research Dive to its repository. As per the report, the market is expected...
Global Radiodermatitis Market Expected to Garner a Revenue of $561.7 Million by 2028, Growing at a CAGR of 4.1% from 2021-2028 – Exclusive Report [169 Pages] By Research Dive
08 nov. 2021 09h00 HE
|
Research Dive
New York, USA, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Research Dive has added a new report to its offering titled, “Radiodermatitis Market by Product (Topical, Oral, and Dressings), Distribution Channel...
Derm-Biome Pharmaceuticals, Inc. reports Positive Results from a Preclinical Study in Atopic Dermatitis: its new generation of compounds are significantly more effective than FDA-approved topical AD drug crisaborole
16 sept. 2021 10h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is pleased to...
Captor Capital’s California Retail Cannabis Dispensaries to Carry Grapefruit’s Patented Hourglass THC/CBD Delivery Cream
06 juil. 2021 06h00 HE
|
Grapefruit USA Inc.
LOS ANGELES, July 06, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Grapefruit USA, Inc. (OTCQB: GPFT) (“Grapefruit” or the “Company”), a premiere California-based cannabis and hemp company, is...
Derm-Biome Pharmaceuticals, Inc. files a US provisional patent for a new generation of natural product-based derivatives and their uses for treating chronic inflammatory skin conditions
29 juin 2021 09h30 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, June 29, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a private Vancouver based biopharmaceutical company focused on skin health and healthy ageing, is...
Global Medical Marijuana Market to Surpass $33,211.7 Million by 2026, with a CAGR of 27.4% Post-COVID-19 Crisis – Exclusive Report [150 Pages] By Research Dive
09 juin 2021 08h40 HE
|
Research Dive
New York, USA, June 09, 2021 (GLOBE NEWSWIRE) -- The new research report on the global medical marijuana market by Research Dive sheds light on the impact of COVID-19 pandemic on the present and...
Derm-Biome Pharmaceuticals, Inc. adds skin disease and microbiome specialists Drs. Youwen Zhou and Andy Sham to Its Newly Created Scientific Advisory Board
02 juin 2021 08h00 HE
|
Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, June 02, 2021 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based preclinical biopharmaceutical company focused on skin health and healthy ageing,...